About this trial

Blood thinner medications used for cardiovascular disease can cause gastrointestinal bleeding. Early detection of invisible bleeding by performing occult fecal blood test (called fecal immunochemical test, or FIT) can uncover serious disease in the stomach and intestine and enable the treating physician to refer the patient for further evaluation.

Eligibility criteria

Qualifiers

Adults aged 18 years or older.

Have an indication to use oral antiplatelet or anticoagulant agent(s).

Absence of past bleeding tendency of gastrointestinal disease.

Agrees to have the test done (FIT).

Disqualifiers

Presence of past bleeding tendency of gastrointestinal disease.

Refusal to have the test done (FIT).

Refusal to sign the informed consent.

Trial design

Treatments tested in this trial

  • Fecal Immunochemical Test (FIT)

Treatment groups

200 Participants
are divided into 1 treatment group

Locations

1
Istishari hospital11184, Amman Jordan

Sponsors and collaborators

Jordan Collaborating Cardiology Group

Lead sponsor